SERCLUTAMAB

UNII:	RY62FD82YX
Formula:
Preferred Substance Name:	SERCLUTAMAB
GSRS Full Record:	RY62FD82YX i

2140172-41-2
IMMUNOGLOBULIN G1(238-CYSTEINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 AM1 S238C .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 AM1 S238C .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EPIDERMAL GROWTH FACTOR RECEPTOR (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, EC=2.7.10.1))MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-446) (VH (HOMO SAPIENS IGHV4-30-4*01 (81%) (IGHD)-IGHJ4*01 (93%)) (9.7.9) (1-116)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(213)), CH2(S9>C(238))) (117-446)), (219-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV14-100*01 (86%) IGKJ1*01/HOMO SAPIENS IGKV1-12*01 (75%) IGKJ4*01 (91%))(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (225-225'':228-228'')-BISDISULFIDE
PR1594407
PR-1594407
SERCLUTAMAB [INN]
SERCLUTAMAB [USAN]
SERCLUTAMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SERCLUTAMAB

Synonyms and Mappings

Resources